The survival of motor neuron (SMN) protein is essential for cytoplasmic assembly of spliceosomal snRNPs. Although the normal proportion of endogenous snRNAs is unevenly altered in spinal muscular atrophy (SMA) tissues, the biogenesis of individual snRNPs is not dramatically affected in SMN-deficient cells. The SMN protein is also required for normal Cajal body (CB) formation, but the functional consequences of CB disruption upon SMN deficiency have not yet been analyzed at the level of macromolecular snRNPs assembly. Here, we show that the SMN protein is required for tri-snRNPs formation and that the level of the minor U4atac/ U6atac/U5 tri-snRNPs is dramatically decreased in lymphoblasts derived from a patient suffering from a severe form of SMA. We found also that splicing of some, but not all, minor introns is inhibited in these cells, demonstrating links between SMN deficiency and differential alterations of splicing events mediated by the minor spliceosome. Our results suggest that SMA might result from the inefficient splicing of one or only a few pre-mRNAs carrying minor introns and coding for proteins required for motor neurons function and/or organization.
INTRODUCTION
Spinal muscular atrophy (SMA) is an autosomal recessive disease characterized by the loss of a-motor neurons within the spinal cord, muscular denervation and atrophy (1) . The disease is due to mutations in the SMN1 gene encoding the survival of motor neuron (SMN) protein (2, 3) , which lead to reduced SMN protein levels and a selective dysfunction of motor neurons. The SMN protein is ubiquitously expressed in all tissues of metazoan organisms and is part of a multiprotein complex containing Gemin 2 -8 and Unrip, which is essential for the formation of the Sm proteins heptameric ring and the association of this complex with the spliceosomal U-snRNAs (4, 5) .
How SMN deficiency causes dysfunction of motor neurons and not other cell types is still an open question. One possibility for explaining SMA is that production of (i) particular mRNA(s) coding for one (or several) component(s) playing a specific function in motor neurons is affected. This hypothesis is supported by studies showing that SMN deficiency alters the stoichiometry of snRNAs in SMN-deficient mouse tissues and causes widespread and tissue-specific pre-mRNA splicing defects in a SMA mouse model (6) . Moreover, the use of a temperature degron allele of SMN in the S. pombe model organism could partially mimic altered snRNPs assembly and intron splicing defects observed in metazoan systems by showing that some introns are more sensitive to low levels of snRNPs than others (7) .
In addition to its role in RNA metabolism, SMN may also function in nucleocytoplasmic, dentritic or axonal transport. Indeed, SMN protein colocalizes with cytoskeletal proteins in dendrites and axons of spinal cord motor neurons in vivo (8, 9) . Moreover, it is found in granules located in neurites and growth cones of cultured neurons (10, 11) .
The SMN protein is present both in the cytoplasm and in the nucleus, where it localizes in Cajal bodies (CBs), nuclear structures identified with antibodies against the marker * To whom correspondence should be addressed. Tel: +33 467613647; Fax: +33 467040231; Email: remy.bordonne@igmm.cnrs.fr or johann.soret@ igmm.cnrs.fr protein p80 coilin and by their high concentration of snRNPs relative to the rest of the nucleus (12, 13) . The reduction in expression of the SMN protein in SMA is also associated with a failure of the SMN complex to assemble into nuclear bodies (3, 14, 15) . Accordingly, using an RNA interference approach, several studies showed that SMN depletion in HeLa cells generate disruption of CB structures (16) (17) (18) . In addition of being a locale for posttranscriptional modifications of snoRNAs and snRNAs, CBs are also sites of U2 snRNP docking and remodeling (19) and are the place where assembly of the U4/U6 di-snRNP and re-assembly of the tri-snRNP might occur (20 -22) . However, these nuclear structures are not essential since many cell types lack morphologically detectable CBs (23, 24) . Moreover, Drosophila knockout mutants of the CB marker coilin are viable and fertile (25) , whereas coilin-knockout mouse lines show semi-lethality with fertility defects (26) . In contrast, coilin is essential for embryogenesis in zebrafish (27) .
While these studies point to a crucial role of CBs as assembly factories of RNPs (28), it is not yet known whether their disruption upon SMN deficiency generates defects in the formation or maturation of individual and higher order snRNPs complexes. In this report, we examined the profiles of snRNPs in cells derived from SMA patients, which contain low SMN levels and residual CBs. We show that SMN-mutated cells contain lower levels of tri-snRNPs and particularly of the minor U4atac/U6atac/U5 tri-snRNP. Our results reveal for the first time that SMA lymphoblasts display differential splicing defects of some but not all minor introns, demonstrating links between SMN deficiency, CB disruption, defect in minor tri-snRNP assembly and inefficient splicing of particular minor introns.
RESULTS

CBs are disrupted in cells derived from SMA patients
Depletion of SMN can be obtained in HeLa cells using targetspecific siRNA duplexes (16 -18) , but homogeneous cell populations are often difficult to obtain hindering biochemical analyses of depleted cells. In order to circumvent this problem, we used fibroblasts and lymphoblasts derived from SMA patients. These cells were chosen because the amount of the SMN protein is decreased in both cell types and because they were derived from patients differing in the severity of the onset although they both correspond to the type I form of SMA. Indeed, fibroblasts GM3813 (3, 29) were obtained from a 3-year-old child, while lymphoblasts GM10684 (30) were derived from a baby who suffered from a more severe SMA and died at 6 months. It has been shown that SMN colocalizes with coilin in CBs in the nucleus of mammalian cells and as expected, colocalization of coilin with SMN in canonical CBs can be observed in the heterozygous SMN+/2 fibroblasts and control SMN+/+ lymphoblasts (Fig. 1) . In contrast, only small and multiple coilin-positive foci are visible upon anti-coilin staining in homozygous SMN2/2 cells (Fig. 1) . These results indicate that both GM3813 fibroblasts and GM10684 lymphoblasts are good models for studying defects induced by SMN mutations and CB disruption on the biogenesis of spliceosomal snRNPs.
Steady-state snRNA levels are not dramatically decreased in cells from SMA patients
As a first step in examining the snRNP catalogue in cells from SMA patients, we performed northern blot analyses to characterize the amount of snRNAs composing the major and minor spliceosome. Indeed, the major (U2-dependent) spliceosome catalyzes the removal of the most common class of U2-type introns, while the less abundant minor (U12-dependent) spliceosome splices the rare U12-type class of pre-mRNA introns (31, 32) . As shown in Figure 2A , no significant changes in the levels of snRNAs occur upon decreased amounts of SMN protein, with the exception, in the SMN2/2 lymphoblasts, of a slight decrease of U4atac and U6atac snRNAs, two components of the minor U12-type spliceosome (31, 33) .
Examination of snRNPs profiles by glycerol gradient sedimentation
Using an RNAi approach, it was previously reported that SMN depletion in HeLa cells does not modify globally the profiles of snRNPs (16) (17) (18) . This result might be a consequence of the high stability of the snRNPs and their long half-live (34) , hindering analysis of SMN loss of function defects on newly synthesized snRNPs. Given that cells from SMA patients carry lower levels of full-length SMN protein than wild-type cells, we first examined snRNPs complexes in extracts by glycerol gradient sedimentation followed by northern blot analysis with probes detecting minor and major spliceosomal snRNAs. When compared to the profiles obtained with extracts from control cells (Fig. 2B , left panel and Supplementary Material, Fig. S1A ), U2 and U1 snRNPs as well as U11 and U12 particles are similarly distributed in both types of cells, indicating that their production is not affected by SMN deficiency. The most striking features observed in the gradients obtained with extracts from SMA patients (Fig. 2B , right panel and Supplementary Material, Fig. S1B ) is a decrease of U4atac/U6atac/U5 minor tri-snRNP as well as U4/U6/U5 major tri-snRNP sedimenting at the bottom of the gradients. Quantification experiments demonstrate that the lower levels of tri-snRNPs in the gradients from SMN2/2 cells are not due to differences in probe specific activity ( Fig. 2C and Supplementary Material, Fig. S1C ).
Formation of U2 and U11 -U12 particles are not impaired in SMN2/2 cells
Given that CBs have been implicated in late assembly steps of the U2 snRNP (19) , and because U12 snRNP shares many components of U2 (32), we next investigated snRNPs formation using antibodies against components of these particles. For U2 and U11 -U12 particles, we used Prp5, a component of the U2 snRNP, and the SF3b155 protein, a component of the Figure 2 . Determination of snRNA levels and characterization of snRNP profiles in cells derived from type I SMA patient. (A) Levels of spliceosomal snRNAs in human cells from type I SMA patients. Equal amounts of total RNA prepared from human fibroblasts of a normal individual (GM3814; SMN+/2) and a type I SMA patient (GM3813; SMN2/2) as well as control lymphoblasts (SMN+/+) and lymphoblasts established from a type I SMA patient (GM10684; SMN2/2) were examined by northern blot analysis. (B) Glycerol gradient sedimentation of major and minor splicing particles. Extracts prepared from the indicated lymphoblasts were fractionated and RNA present in each fraction analyzed by northern blot. The fraction numbers and the positions of snRNP complexes are shown at the bottom. The direction of sedimentation is from top to bottom, as indicated by the arrow. (C) The amounts of U4 and U6 as well as U4atac and U6atac RNAs found on the gradients shown in (B) were quantified using the Syngene Genetools software. The abundance of snRNAs in each fraction (percentage of total) was calculated as the number of counts in each fraction divided by the sum of the counts in all fractions.
U2 snRNP and U11 -U12 di-snRNP (32) . As shown in Figure 3 , both U2 snRNP and U11 -U12 di-snRNPs were efficiently immunoprecipitated with these antibodies in both SMN2/2 cells and in control cells. These results show that SMN deficiency does not affect the production of U2 and U11 -U12 particles supporting data obtained by glycerol gradient sedimentation.
Formation of the minor U4atac/U6atac/U5 snRNP is hindered in cells derived from SMA patients Given that CBs might be sites for tri-snRNPs assembly and in order to confirm defects in tri-snRNPs formation observed by glycerol gradient sedimentation, we analyzed the snRNPs composition in extracts by immunoprecipitation and northern blot analyzes using antibodies against components of the U5 snRNP as well as of the minor and major tri-snRNPs (32) . Using antibodies against the 110K tri-snRNPs specific protein, almost equal amounts of major snRNAs were precipitated from the fibroblasts extracts whereas a significant 2-fold decrease (P , 0.001) in the levels of minor U4atac and U6atac snRNAs was observed in the immunopellet of the SMN2/2 fibroblasts (Fig. 4A) . Using the same antibodies but extracts from lymphoblasts, a stronger decrease in the level of U4atac and U6atac is observed in the SMN2/2 cells while similar amounts of U5 and 50% of the amount of U4 and U6 snRNAs are immunoprecipitated when compared with SMN+/+ lymphoblasts (Fig. 4B) . The observed difference is not due to discrepancies in the relative amount of snRNPs in the extracts as demonstrated by immunoprecipitation using anti-Sm antibodies which show that equal amounts of snRNAs were precipitated from SMN2/2 and control cells (Fig. 4C) . To prove further that the level of the SMN protein is important for tri-snRNPs formation, similar analyses were performed with antibodies against the U5-100K and U5-40K proteins, which are also associated with the minor and major tri-snRNPs (32) . As shown in Figure 4D and E, only trace amounts of U4atac and U6atac and substantially less U4 and U6 snRNAs can be found in the pellets of SMN2/2 lymphoblasts while U5 is efficiently immunoprecipitated with both antibodies. Based on quantification of the experiments performed with anti-100K and anti-40K antibodies, we found an 25-fold decrease in the amount of the minor tri-snRNP and an 2-fold decrease in that of the major tri-snRNP in SMN2/2 lymphoblasts when compared with control. Altogether, these studies point to a correlation between the amounts of minor U4atac/U6atac/U5 tri-snRNP and the severity of the disease.
Differential splicing defects of minor introns in lymphoblasts derived from SMA patients
To test whether decreased levels of minor U4atac/U6atac/U5 tri-snRNPs give rise to splicing defects of U12-type introns, we analyzed the splicing efficiency of 30 out of the 700 minor introns identified in the human genome and referenced in the U12 database (http://genome.crg.es/datasets/u12/). Clear splicing inhibition of minor introns could be detected for some ( 10%) (Fig. 5A ), but not all (Fig. 5B) , tested introns in SMA lymphoblasts, demonstrating that minor introns react differentially when the level of minor tri-snRNPs is strongly decreased. In contrast, no retention of minor introns could be detected in the SMA fibroblasts (Supplementary Material, Fig. S2 ), indicating that a moderate decrease in the amount of minor tri-snRNPs does not generate splicing defects.
DISCUSSION
In this study, we used cells derived from SMA patients to test for the effects of SMN mutations on higher order formation of macromolecular complexes involved in splicing of nuclear pre-mRNAs. We found that SMN deficiency gives rise to defects in the formation of the tri-snRNPs and particularly of the U4atac/U6atac/U5 minor tri-snRNPs, a component of the U12-dependent (minor) spliceosome. Remarkably, we show that minor introns are differentially spliced when the level of minor tri-snRNP is strongly reduced by 25-fold leading to differential splicing inhibition of U12-type introns.
The SMN complex plays an essential role in the assembly of the heptameric Sm proteins core complex and in the association of this complex to the snRNAs (4, 5) . Using various models, numerous studies clearly established a correlation between SMN deficiency, alterations in snRNP assembly and splicing (6, 7, 35) , suggesting that SMA is a general splicing disease. Other studies show that the SMN protein is required for correct CB homeostasis which is consistent with previous observations showing the loss of discrete SMN and coilin containing foci in a mouse model of SMA (15) . It was generally assumed that SMA might be a consequence of rate limiting levels of snRNPs due to low levels of SMN protein, but snRNP synthesis was not significantly affected or only modestly reduced in cells from SMA patients or in tissues of a SMA mouse model (6, 35) . It was also reported that SMN deficiency alters the repertoire of snRNAs in cells derived from SMA mice as well as in cells depleted of SMN by RNAi (6, 35) . Indeed, using this last approach, decrease of SMN levels in HeLa cells to 5% of normal resulted in a reduction of most of the snRNAs except U2 and U6, whereas reduction of SMN levels to 10% of normal in a mouse neuron-derived cell line generated a small increase in U1 snRNA and a large decrease in U11 snRNA (6) . Noteworthy, SMN protein levels in the shRNA-treated cells (6) or in different tissues of two SMA mouse models (6, 35) are significantly more decreased (10 -15% of controls) than in cells derived from type I SMA patients (40 -50% of the control) (3, 30) . Altogether, these observations support the notion that alterations in snRNPs production could occur in response to extremely low SMN levels, a condition that may not reflect the situation of most SMA cases. While our data are in agreement with the view that SMA is not caused by global depletion of spliceosomal snRNPs, they indicate that SMA might be the outcome of defects due to disruption and dysfunction of CBs in the assembly and/or recycling of the minor U4atac/U6atac/U5 tri-snRNP rather than a decrease in the levels or a change in the profiles of snRNAs.
The observed difference in the amount of minor tri-snRNPs found in SMN2/2 lymphoblasts compared with SMNdeficient fibroblasts points to a correlation between the severity of the disease and defects in minor tri-snRNPs production.
In this regard, it is possible that minor tri-snRNPs assembly is less affected in SMN2/2 fibroblasts because of higher U4atac and U6atac snRNAs levels ( Fig. 2A) or because of differential regulatory potentials in the different cellular backgrounds. Altogether, our data suggest the following model for snRNP biogenesis in SMN2/2 cells (Fig. 6 ): due to CB disruption and to the low abundance of U4atac and U6atac, formation of minor tri-snRNP is impeded in the nucleoplasm of SMN2/2 lymphoblasts. In contrast, assembly of the major tri-snRNPs can still occur (albeit at a lower rate) since U4 and U6 snRNPs are usually found at 100-fold higher levels. Our findings are in agreement with previous studies showing that U4/U6 di-snRNP accumulates in CBs when tri-snRNP formation is blocked (20, 22, 36) and with data showing that the rate of U4/U6 di-snRNP assembly is increased by 10-fold in cells having at least one CB (21) . Consistent with a recent report showing that the capability to form CBs enhances the rate of snRNPs biogenesis during zebrafish embryogenesis (27) , our data support the view that CB function as locale accelerating the assembly of macromolecular complexes by increasing the relative concentration of components (28) .
Our results show that a moderate decrease in the level of the minor U4atac/U6atac/U5 tri-snRNPs does not affect splicing Figure 4 . Formation of minor tri-snRNP is impeded in cells derived from type I SMA patients. (A) Antibodies against the 110K tri-snRNP specific protein were used to immunoprecipitate snRNPs from extracts prepared from control GM3814 (SMN+/2) and SMA I patient (GM3813; SMN2/2) fibroblasts. The immunoprecipitated snRNAs were characterized by northern blot analyses using radioactive oligonucleotide probes complementary to snRNA sequences. (B-E) Immunoprecipitation experiments were performed with antibodies against 110K tri-snRNPs specific protein, and against the 100K and 40K proteins, which are components of U5 as well as tri-snRNPs. Anti-Sm antibodies were used as control of the relative amount of snRNPs in the extracts. Extracts were prepared from control lymphoblasts (SMN+/+) and lymphoblasts established from a type I SMA patient (GM10684; SMN2/2). The immunoprecipitated snRNAs were analyzed by northern blot. Note that the loading order is not similar in all panels.
of minor introns. This is consistent with previous studies showing that a 5-fold reduction in the number of U12-type spliceosome does not limit the processing of endogenous U12-type introns (37) . However, it has been shown that the number of U12-dependent spliceosomes could become limiting in cells carrying low levels of U4atac and a large excess of an RNA reporter containing a U12-type intron (37) . A similar inhibitory effect was observed by overexpression of a transiently transfected reporter gene carrying a U12-type intron into Drosophila S2 cells (38) . These results are consistent with our data showing that a 25-fold decrease in the level of the minor tri-snRNP in lymphoblasts leads to a differential retention of minor introns in vivo. It is possible that the amount of minor tri-snRNPs becomes limiting for some pre-mRNAs and it is conceivable that introns containing suboptimal splicing signals are more sensitive to decreased levels of U12-type spliceosomes. However, no obvious common features emerged from the comparison of the retained and unaffected minor introns and further identification of more introns of each class will be required to find statistically significant common determinants.
It is noteworthy that among the characterized retained minor introns, one is located in the ATXN10 gene known to play a role in neuron survival, neuron differentiation and neuritogenesis (39, 40) . In this regard and while it is clearly established that a reduced amount of SMN protein is responsible for SMA, the molecular mechanism by which this deficiency induces the specific degeneration of motor neurons remains unknown. Based on the proposal that mis-regulation of neuronal actin dynamics is central to SMA pathogenesis (41) , it is interesting to note that a high proportion of U12-type introns are concentrated in genes involved in functions related to cytoskeletal organization (42, 43) . Given that the U12-dependent spliceosome acts as a regulator of gene expression by adjusting mRNA levels, our results support the view that SMA might result from the inefficient splicing of one or only a few pre-mRNAs carrying minor introns and coding for proteins required for motor neuron function and/ 6 . Model of tri-snRNPs assembly in SMN2/2 lymphoblasts. Due to higher levels of U4, U5 and U6 snRNPs, tri-snRNP formation of the major particles can occur in the nucleoplasm even when CBs are disrupted as it is the case in SMN2/2 cells. In contrast, the formation of minor tri-snRNP is impaired because the amounts of minor U4atac and U6atac snRNPs are 100-fold lower when compared to the snRNPs from the major spliceosome.
or organization. The identification of these pre-mRNAs will certainly bring insights into the molecular mechanisms responsible for the development of the SMA disease and might also help in defining new therapies.
MATERIALS AND METHODS
Cell culture and extract preparation
For preparation of whole cell extracts, cells were harvested in the HNTG buffer (20 mM HEPES pH 7.9, 150 mM NaCl, 1% Triton X-100, 10% glycerol, 1 mM MgCl 2 , 1mM EGTA, 1 mM phenylmethylsulfonyl fluoride, protease inhibitor mixture) and lysed on ice for 20 min. After centrifugation at 15 000g (10 min, 48C), supernatants were carefully removed and used for western analysis or immunoprecipitation experiments.
Glycerol gradient sedimentation analysis
Extracts were diluted 3-fold with buffer A (50 mM Tris-Cl pH 7.4, 25 mM NaCl, 5 mM MgCl 2 ) and layered on 11 ml 10-30% (wt/vol) glycerol gradients in buffer A. After sedimentation at 37 000 rpm for 14 h in a SW41 rotor at 48C, fractions of 400 ml were recovered and extracted with an equal volume of phenol-chloroform, ethanol precipitated and resuspended in 10 ml of loading buffer (99% formamide, 0.02% xylene cyanol, 0.02% bromophenol blue). The RNA samples were then subjected to northern blot analysis as described (44) . The sequences of the oligonucleotides used as probes are available upon request.
Immunoprecipitation
Antibodies were incubated with protein A-Sepharose CL-4B beads for 2 h at 48C. Extracts were added and rotated with beads for 2 h at 48C. Beads were washed five times with IP150 buffer (20 mM Tris-Cl pH 7.4, 150 mM NaCl, 5 mM MgCl 2 , 0.1% Nonidet P-40) and the immunopellet was extracted with an equal volume of phenol-chloroform, ethanol precipitated and analyzed by northern blot. Anti-100K, anti-110K, anti-Prp5 and anti-SF3b155 were purchased from Bethyl-Laboratories. Anti-40K antibodies were a gift from R. Lührmann and anti-Sm from A. Bindereif.
RT -PCR analysis
For semi-quantitative RT -PCR analyses, total RNA was purified from cells with Tri-Reagent (Sigma) according to the manufacturer's procedure and treated with RQ1 RNase free DNase (Promega). First-strand cDNAs were synthesized from 5 mg of total RNA and pd(N)6 random oligonucleotides with the First-Strand cDNA synthesis kit (GE-Healthcare). For RT -PCR analyses, one-tenth of the reaction was amplified with GoTaq polymerase (Promega) in a volume of 50 ml containing 20 pmol of primer pairs, 200 mM dNTPs and 1.5 mM MgCl 2 in 1x GoTaq buffer and sequentially cycled 26 times. Linearity of amplification was observed for at least 30 cycles as tested by the addition of [a -32 P]-dCTP (3000 Ci/mmol) in the final cycles (data not shown). Primer sequences and PCR regimes are available on request. The PCR products were separated on 1.5-2.5% agarose gels containing ethidium bromide and visualized under UV light. The gel images were digitally captured and analysed using Syngene Genetools software.
Immunofluorescence
Immunofluorescence was performed on cells grown on cover slips or cytospinned, washed twice in PBS and fixed in 4% (w/v) paraformaldehyde in PBS at room temperature, followed by permeabilization with 0.1% Triton X-100 in PBS for 5 min at room temperature. p80 coilin (gift from A. Lamond) was detected with a polyclonal rabbit anti-coilin (1:400 dilution) and anti-SMN (mAb BD Transduction Laboratories) was used at 1:1000. Incubations were for 1 h at 258C in PBS containing 2% bovine serum albumin, and slides were then washed three times for 3 min in PBS. Secondary antibodies were diluted according to the supplier's instructions. Cover slips were mounted on glass slides using mounting medium (Vectashield), and the samples were observed using a Leica fluorescence microscope. Images were acquired with a Coolsnap camera (Photometrics) controlled by the Metamorph software (Universal Imaging).
